Biomedical Bonding AB Advances Bonevolent® AdhFix Toward Veterinary Clinical Use

Biomedical Bonding AB Advances Bonevolent® AdhFix Toward Veterinary Clinical Use

Biomedical Bonding AB has taken another important step toward the veterinary clinical implementation of its Bonevolent® AdhFix technology through an intensive full-day hands-on training session conducted together with veterinary surgeons participating in the company’s upcoming clinical studies.

These challenges align closely with the strengths of Bonevolent® AdhFix, an injectable and light-curable fixation technology that allows surgeons to shape the implant directly during surgery to match the patient’s unique anatomy.

The session began with a technical walkthrough led by Michael Malkoch, focusing on the underlying principles of the AdhFix® composite and its integration with existing fixation approaches. This was followed by practical exercises using PEEK rod fracture models, designed to simulate small bone fractures.

After an initial guided demonstration, the session transitioned into independent trials, where the surgeons explored different screw configurations and fixation strategies aligned with relevant clinical scenarios.

The session further progressed to testing on feline bone specimens, enabling discussion around potential applications in veterinary fracture indications particularly in cats, where anatomical constraints often limit the use of conventional fixation methods.

The interaction supported both increased familiarity with the material and valuable feedback on handling and application. These insights contribute to ongoing usability development and the evaluation of AdhFix® across different surgical contexts.

“This is an exciting new technology for fracture fixation, and a wonderful example of translational medicine — an innovative technique moving from laboratory research toward clinical application.”— Prof. Odd Viking Höglund, Swedish University of Agricultural Sciences (SLU)

Biomedical Bonding AB would like to thank everyone involved for their support and collaboration in advancing AdhFix toward veterinary clinical practice.